Laura Jane Mackenzie

Ms. Laura Jane Mackenzie

Physiotherapy, University of Canberra, Canberra, Australian Capital Territory, Australia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in Exploratory Research in Clinical and Social Pharmacy
Verified
Journal Article
Open access
Laura Jane MackenzieLaura Jane Mackenzie
Laura Jane Mackenzie
MBMary-Jessimine A. Bushell
Mary-Jessimine A. Bushell
PNPhillip Newman
Phillip Newman
JBJaquelin Anne Bousie
Jaquelin Anne Bousie
Background: Shoulder injury related to vaccine administration (SIRVA) has been recognised as the compensable term for any shoulder injury that may result from an improper vaccination technique since 2017, however, its incidence and impact remain poorly understood. Objectives: To examine knowledge of SIRVA through reported cases, determine SIRVA incidence related to COVID-19 vaccinations, and investigate recovery rates. Methods: Six pharmacovigilance agencies in the United States of America (USA), Canada, United Kingdom, European Union, Australia, and New Zealand were systematically search to identify all reported cases of SIRVA between January 2017 to July 2021. Primary outcome measures were SIRVA case reports. Secondary outcome measures included recovery status as well as vaccine received, age, and sex. SIRVA-related outcome measures were retrieved between July 18th and July 22nd 2021, with UK data received via personal correspondence. Results: Retrospective analysis yielded 505 SIRVA cases since 2017, with 330 (65%) of cases reported from January to July 2021. Sub-analysis, using COVID-19 data of 189 SIRVA cases from 891,906,986 vaccinations, estimated incidence to be 2 per 10 million. 32 cases (7%) had recovered from symptoms at the time of reporting, with 311 (62%) reported as 'not recovered', and 162 cases (32%) 'unknown'. Females represented 75% of reported cases. Conclusion: SIRVA case report numbers and incidence from COVID-19 data, compared with prior evidence, raises questions around health practitioner knowledge and reporting accuracy of SIRVA. Recovery rates are poorly understood. A global consensus definition of SIRVA and more transparent and routine reporting is required. The disproportionate representation of females is of concern with no known reasons for this disparity. Further research is needed on SIRVA knowledge in healthcare practitioners, reporting rates, incidence, management, and long-term outcomes for those impacted. Pharmacist vaccinators should be aware of their role in preventing SIRVA and be active in its detection.

23 November 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Laura Jane MackenzieLaura Jane Mackenzie
Laura Jane Mackenzie
JBJaquelin Anne Bousie
Jaquelin Anne Bousie
PNPhil Newman
Phil Newman
JWJanique Waghorn
Janique Waghorn
JCJohn Edward Cunningham
John Edward Cunningham
MBMary-Jessimine Bushell
Mary-Jessimine Bushell
Background: Vaccine pharmacovigilance is at the forefront of the public eye. Shoulder Injuries Related to Vaccine Administration (SIRVA) is a poorly understood Adverse Event Following Immunisation, with iatrogenic origins. Criteria for medicolegal diagnosis of SIRVA is conflicting, current literature and educational materials are lacking, and healthcare practitioner knowledge of the condition is unknown. Methods: A cross-sectional, convenience sampled survey, utilising a validated online questionnaire assessed practitioner knowledge of SIRVA, safe injecting, and upper limb anatomy, and preferred definition for SIRVA. Results: Mean scores were moderate for safe injecting knowledge (69%), and poor for knowledge of anatomy (42%) and SIRVA (55%). Non-immunising healthcare practitioners scored significantly (p = 0.01, and < 0.05, respectively) higher than immunising practitioners for anatomy (2.213 ± 1.52 vs. 3.12 ± 1.50), and safe injecting knowledge (6.70 ± 1.34 vs. 7.14 ± 1.27). Only 52% of authorised vaccinators accurately selected a 40 × 20 mm area recommended for safe injecting. Majority (91.7%) of respondents thought nerve injuries should be included in the diagnostic criteria for SIRVA. Discussion and conclusions: Greater education and awareness of SIRVA is needed in all healthcare disciplines. Consensus regarding SIRVA definition is paramount for accurate reporting and improved future understanding of all aspects of SIRVA.

20 February 2025 in Vaccine
Verified
Journal Article
Open access
Laura Jane MackenzieLaura Jane Mackenzie
Laura Jane Mackenzie
JBJaquelin Anne Bousie
Jaquelin Anne Bousie
PNPhillip Newman
Phillip Newman
JCJohn Cunningham
John Cunningham
AWAndrew P. Woodward
Andrew P. Woodward
MBMary-Jessimine Ann Bushell
Mary-Jessimine Ann Bushell
Shoulder injury related to vaccine administration (SIRVA) has been reported to be a rare but real complication of vaccination. It is considered attributable to an incorrect vaccine administration technique by the vaccinator. To date, evidence about SIRVA is mainly limited to case studies and case series, and the incidence remains unknown. This study aimed to determine the incidence of SIRVA. We conducted a retrospective study of the publicly available Eudravigilance database (pharmacovigilance data). We examined all COVID-19 vaccine case reports administered between January 2020 and December 2022. Reports were analysed to see if they met the Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC) definition and inclusion criteria for SIRVA. Data was extracted. Between January 2020, and December 2022, from 1,172,583,008 administered COVID-19 vaccines, 43,192 cases met the SAEFVIC inclusion criteria for SIRVA. This equals an incidence of 3·7 cases per 100,000 vaccines administered during the three years. Female subjects are disproportionately affected, with 33,828 cases (77.9 %). The incidence was higher with some COVID-19 vaccine formulations than others. The incidence found in this study is higher than previously reported. The data also reflects that it affects more female subjects than males. While previously considered avoidable using the correct vaccine administration technique, the data challenges this notion as it shows that certain vaccine formulations may be associated with a higher incidence of the condition. The causes of SIRVA are likely multifaceted, with current understanding being further impacted by unclear definitions and reporting requirements. This project was supported by an ECARD grant from The University of Canberra.

27 June 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
Laura Jane MackenzieLaura Jane Mackenzie
Laura Jane Mackenzie
JBJaquelin Anne Bousie
Jaquelin Anne Bousie
MBMary-Jessimine Bushell
Mary-Jessimine Bushell
PNPhil Newman
Phil Newman
This study presents a case of SIRVA-induced adhesive capsulitis and the subsequent physiotherapy intervention. It details the patient’s journey using CARE guidelines. The main symptoms included persistent pain and a reduced range of motion for flexion, abduction, and internal and external rotation of the shoulder. Interventions included active and passive mobilisation via capsular stretching, and home exercise programs. At more than two years post-injury, the patient has ongoing pain, restricted shoulder movement, and disability. This highlights the importance of healthcare practitioners’ knowledge of SIRVA. Vaccinating practitioners should be aware of the mechanism of injury of SIRVA for preventing such injuries. First-contact practitioners should be aware of SIRVA-induced conditions to ensure timely and correct diagnosis and management of SIRVA-induced conditions.